Current management of Alström syndrome and recent advances in treatment

References

• Alstrom CH, Hallgren B, Nilsson LB, et al. Retinal degeneration combined with obesity, diabetes mellitus and neurogenous deafness: a specific syndrome (not hitherto described) distinct from the Laurence-Moon-Bardet-Biedl syndrome: a clinical, endocrinological and genetic examination based on a large pedigree. Acta Psychiatr Neurol Scand Suppl. 1959;129:1–35.
   PubMedGoogle Scholar
• Hearn T, Renforth GL, Spalluto C, et al. Mutation of ALMS1, a large gene with a tandem repeat encoding 47 amino acids, causes Alström syndrome. Nat Genet. 2002 May;31(1):79–83.
   PubMed Web of Science ®Google Scholar
• Collin GB, Marshall JD, Ikeda A, et al. Mutations in ALMS1 cause obesity, type 2 diabetes and neurosensory degeneration in Alström syndrome. Nat Genet. 2002 May;31(1):74–78.
   PubMed Web of Science ®Google Scholar
• Hearn T, Spalluto C, Phillips VJ, et al. Subcellular localization of ALMS1 supports involvement of centrosome and basal body dysfunction in the pathogenesis of obesity, insulin resistance, and type 2 diabetes. Diabetes. 2005 May;54(5):1581–1587.
   PubMed Web of Science ®Google Scholar
• Akdeniz N, Bilgili SG, Aktar S, et al. Alström syndrome with acanthosis nigricans: a case report and literature review. Genet Couns. 2011;22(4):393–400.
   PubMed Web of Science ®Google Scholar
• Michaud JL, Héon E, Guilbert F, et al. Natural history of Alström syndrome in early childhood: onset with dilated cardiomyopathy. J Pediatr. 1996 Feb;128(2):225–229.
   PubMed Web of Science ®Google Scholar
• Bond J, Flintoff K, Higgins J, et al. The importance of seeking ALMS1 mutations in infants with dilated cardiomyopathy. J Med Genet. 2005 Feb;42(2):e10.
   Google Scholar
• Loudon MA, Bellenger NG, Carey CM, et al. Cardiac magnetic resonance imaging in Alström syndrome. Orphanet J Rare Dis. 2009;4:14.
   PubMed Web of Science ®Google Scholar
• Edwards NC, Moody WE, Yuan M, et al. Diffuse left ventricular interstitial fibrosis is associated with sub-clinical myocardial dysfunction in Alström syndrome: an observational study. Orphanet J Rare Dis. 2015;10:83.
   PubMed Web of Science ®Google Scholar
• Paisey RB, Carey CM, Bower L, et al. Hypertriglyceridaemia in Alström’s syndrome: causes and associations in 37 cases. Clin Endocrinol (Oxf). 2004 Feb;60(2):228–231.
   PubMed Web of Science ®Google Scholar
• Paisey R, Barrett T, Carey C, et al. Rare disorders presenting in the diabetic clinic: an example using audit of the NSCT adult Alström clinics. Pract Diabetes. 2011;28(8):340–343.
   Google Scholar
• Marshall JD, Bronson RT, Collin GB, et al. New Alström syndrome phenotypes based on the evaluation of 182 cases. Arch Intern Med. 2005 Mar 28;165(6):675–683.
   PubMedGoogle Scholar
• Jatti K, Paisey R, More R. Coronary artery disease in Alström syndrome. Eur J Hum Genet. 2012 Jan;20(1):117–118.
   PubMed Web of Science ®Google Scholar
• Citton V, Favaro A, Bettini V, et al. Brain involvement in Alström syndrome. Orphanet J Rare Dis. 2013;8:24.
   PubMed Web of Science ®Google Scholar
• Collin GB, Marshall JD, King BL, et al. The Alström syndrome protein, ALMS1, interacts with α-actinin and components of the endosome recycling pathway. PLoS One. 2012;7(5):e37925.
   Google Scholar
• Xu Y, Guan L, Xiao X, et al. ALMS1 null mutations: a common cause of Leber congenital amaurosis and early-onset severe cone-rod dystrophy. Clin Genet. 2015;89:442–447.
   Web of Science ®Google Scholar
• Marshall JD, Maffei P, Beck S, et al. Clinical utility gene card for: Alström syndrome. Eur J Hum Genet [Internet]. 2011Oct [cited 2012 Aug 14]; 19(10). Available from: http://www.ncbi.nlm.nih.gov/pubmed/21522186.
   Google Scholar
• Muresan V, Joshi HC, Besharse JC. Gamma-tubulin in differentiated cell types: localization in the vicinity of basal bodies in retinal photoreceptors and ciliated epithelia. J Cell Sci. 1993 Apr;104(Pt 4):1229–1237.
   PubMed Web of Science ®Google Scholar
• Paisey R. Ciliopathies: a reference for clinicians. In: Kenny, TD, Beales PL, editors. Alström syndrome. 1st ed. New York, NY: Oxford University Press; 2013.
   Google Scholar
• Home - Alstrom Syndrome UK [Internet]. [ cited 2016 Apr 13]. Available from: http://www.alstrom.org.uk/.
   Google Scholar
• About ASI |Alström Syndrome International [Internet]. [ cited 2016 Apr 18]. Available from: https://www.alstrom.org/about/.
   Google Scholar
• Van Groenendael S, Giacovazzi L, Davison F, et al. High quality, patient centred and coordinated care for Alstrom syndrome: a model of care for an ultra-rare disease. Orphanet J Rare Dis. 2015;10:149.
   PubMed Web of Science ®Google Scholar
• Zulato E, Favaretto F, Veronese C, et al. ALMS1-deficient fibroblasts over-express extra-cellular matrix components, display cell cycle delay and are resistant to apoptosis. PLoS One. 2011;6(4):e19081.
   Web of Science ®Google Scholar
• Romano S, Milan G, Veronese C, et al. Regulation of Alström syndrome gene expression during adipogenesis and its relationship with fat cell insulin sensitivity. Int J Mol Med. 2008 Jun;21(6):731–736.
   PubMed Web of Science ®Google Scholar
• Koray F, Dorter C, Benderli Y, et al. Alstrom syndrome: a case report. J Oral Sci. 2001 Sep;43(3):221–224.
   PubMedGoogle Scholar
• Iannello S, Bosco P, Camuto M, et al. A mild form of Alstrom disease associated with metabolic syndrome and very high fasting serum free fatty acids: two cases diagnosed in adult age. Am J Med Sci. 2004 May;327(5):284–288.
   PubMed Web of Science ®Google Scholar
• Hamamy H, Barham M, Alkhawaldeh A-E, et al. Alstrom syndrome in four sibs from northern Jordan. Ann Saudi Med. 2006 Dec;26(6):480–483.
   PubMed Web of Science ®Google Scholar
• Koç E, Bayrak G, Suher M, et al. Rare case of Alstrom syndrome without obesity and with short stature, diagnosed in adulthood. Nephrology (Carlton). 2006 Apr;11(2):81–84.
   PubMed Web of Science ®Google Scholar
• Tiwari A, Awasthi D, Tayal S, et al. Alstrom syndrome: A rare genetic disorder and its anaesthetic significance. Indian J Anaesth. 2010 Mar;54(2):154–156.
   PubMedGoogle Scholar
• Zmyslowska A, Borowiec M, Antosik K, et al. Genetic evaluation of patients with Alström syndrome in the Polish population. Clin Genet. 2015;89:448–455.
   Web of Science ®Google Scholar
• Ozantürk A, Marshall JD, Collin GB, et al. The phenotypic and molecular genetic spectrum of Alström syndrome in 44 Turkish kindreds and a literature review of Alström syndrome in Turkey. J Hum Genet. 2015 Jan;60(1):1–9.
   PubMed Web of Science ®Google Scholar
• Marshall JD, Ludman MD, Shea SE, et al. Genealogy, natural history, and phenotype of Alström syndrome in a large Acadian kindred and three additional families. Am J Med Genet. 1997 Dec 12;73(2):150–161.
   PubMed Web of Science ®Google Scholar
• Aldahmesh MA, Abu-Safieh L, Khan AO, et al. Allelic heterogeneity in inbred populations: the Saudi experience with Alström syndrome as an illustrative example. Am J Med Genet A. 2009 Feb 15;149A(4):662–665.
   PubMed Web of Science ®Google Scholar
• Marshall JD, Hinman EG, Collin GB, et al. Spectrum of ALMS1 variants and evaluation of genotype-phenotype correlations in Alström syndrome. Hum Mutat. 2007 Nov;28(11):1114–1123.
   PubMed Web of Science ®Google Scholar
• Joy T, Cao H, Black G, et al. Alstrom syndrome (OMIM 203800): a case report and literature review. Orphanet J Rare Dis. 2007;2:49.
   PubMed Web of Science ®Google Scholar
• Marshall JD, Muller J, Collin GB, et al. Alström syndrome: mutation spectrum of ALMS1. Hum Mutat. 2015 Jul;36(7):660–668.
   PubMed Web of Science ®Google Scholar
• Redin C, Le Gras S, Mhamdi O, et al. Targeted high-throughput sequencing for diagnosis of genetically heterogeneous diseases: efficient mutation detection in Bardet-Biedl and Alstrom syndromes. J Med Genet [Internet]. 2012 Jul 7 [cited 2012 Aug 14]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22773737.
   Google Scholar
• Collin GB, Cyr E, Bronson R, et al. Alms1-disrupted mice recapitulate human Alström syndrome. Hum Mol Genet. 2005 Aug 15;14(16):2323–2333.
   PubMed Web of Science ®Google Scholar
• Arsov T, Silva DG, O’Bryan MK, et al. Fat aussie–a new Alström syndrome mouse showing a critical role for ALMS1 in obesity, diabetes, and spermatogenesis. Mol Endocrinol. 2006 Jul;20(7):1610–1622.
   PubMed Web of Science ®Google Scholar
• Shenje LT, Andersen P, Halushka MK, et al. Mutations in Alström protein impair terminal differentiation of cardiomyocytes. Nat Commun. 2014 Mar 4;5:3416.
   PubMed Web of Science ®Google Scholar
• Lodh S, Hostelley TL, Leitch CC, et al. Differential effects on β-cell mass by disruption of Bardet-Biedl syndrome or Alstrom syndrome genes. Hum Mol Genet. 2016 Jan 1;25(1):57–68.
   PubMed Web of Science ®Google Scholar
• Leitch CC, Lodh S, Prieto-Echagüe V, et al. Basal body proteins regulate Notch signaling through endosomal trafficking. J Cell Sci. 2014 Jun 1;127(Pt 11):2407–2419.
   PubMed Web of Science ®Google Scholar
• Jacobson SG, Cideciyan AV, Aguirre GD, et al. Improvement in vision: a new goal for treatment of hereditary retinal degenerations. Expert Opin Orphan Drugs. 2015 May 4;3(5):563–575.
   PubMed Web of Science ®Google Scholar
• Jagger DJ, Forge A. Assessing PCP in the cochlea of mammalian ciliopathy models. Methods Mol Biol. 2012;839:239–248.
   PubMedGoogle Scholar
• Jagger D, Collin G, Kelly J, et al. Alström Syndrome protein ALMS1 localizes to basal bodies of cochlear hair cells and regulates cilium-dependent planar cell polarity. Hum Mol Genet. 2011 Feb 1;20(3):466–481.
   PubMed Web of Science ®Google Scholar
• Rönnåsen B, Möller K, Möller C, et al. Aspects of learning from the perspective of people with Alström syndrome. Disabil Rehabil. 2016 Apr;38(7):644–652.
   PubMed Web of Science ®Google Scholar
• Hitz M-P, Bertram H, Köditz H, et al. Levosimendan for bridging in a pediatric patient with Alström syndrome awaiting heart-lung transplantation. Clin Res Cardiol. 2008 Nov;97(11):846–848.
   PubMed Web of Science ®Google Scholar
• Lee N-C, Marshall JD, Collin GB, et al. Caloric restriction in Alström syndrome prevents hyperinsulinemia. Am J Med Genet A. 2009 Feb 15;149A(4):666–668.
   PubMed Web of Science ®Google Scholar
• Bettini V, Maffei P, Pagano C, et al. The progression from obesity to type 2 diabetes in Alström syndrome. Pediatr Diabetes. 2012 Feb;13(1):59–67.
   PubMed Web of Science ®Google Scholar
• Mokashi A, Cummings EA. Presentation and course of diabetes in children and adolescents with Alstrom syndrome. Pediatr Diabetes. 2011 May;12(3 Pt 2):270–275.
   PubMed Web of Science ®Google Scholar
• Connolly MB, Jan JE, Couch RM, et al. Hepatic dysfunction in Alström disease. Am J Med Genet. 1991 Sep 15;40(4):421–424.
   PubMed Web of Science ®Google Scholar
• Awazu M, Tanaka T, Sato S, et al. Hepatic dysfunction in two sibs with Alström syndrome: case report and review of the literature. Am J Med Genet. 1997 Mar 3;69(1):13–16.
   PubMed Web of Science ®Google Scholar
• Hayashi T, Wojtaszewski JFP, Goodyear LJ. Exercise regulation of glucose transport in skeletal muscle. Am J Physiol Endocrinol Metab. 1997 Dec 1;273(6):E1039–51.
   Google Scholar
• Paisey RB, Geberhiwot T, Waterson M, et al. Modification of severe insulin resistant diabetes in response to lifestyle changes in Alström syndrome. Eur J Med Genet. 2014 Feb;57(2–3):71–75.
   PubMed Web of Science ®Google Scholar
• Johnston DG, Alberti KG, Binder C, et al. Hormonal and metabolic changes in hepatic cirrhosis. Horm Metab Res. 1982 Jan;14(1):34–39.
   PubMed Web of Science ®Google Scholar
• Saisho Y, Kou K, Tanaka K, et al. Postprandial serum C-peptide to plasma glucose ratio as a predictor of subsequent insulin treatment in patients with type 2 diabetes. Endocr J. 2011;58(4):315–322.
   PubMed Web of Science ®Google Scholar
• Jones AG, Hattersley AT. The clinical utility of C-peptide measurement in the care of patients with diabetes. Diabet Med. 2013 Jul;30(7):803–817.
   PubMed Web of Science ®Google Scholar
• Lindström J, Ilanne-Parikka P, Peltonen M, et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet. 2006 Nov;368(9548):1673–1679.
   PubMed Web of Science ®Google Scholar
• Diabetes Prevention Program Resea. 10-year follow-up of diabetes incidence and weight loss in the diabetes prevention program outcomes study. The Lancet. 2009 Nov 14;374(9702):1677–1686.
   PubMed Web of Science ®Google Scholar
• Wing RR, Bolin P, Brancati FL, et al. Look AHEAD Research Group. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013 Jul 11;369(2):145–154.
   PubMed Web of Science ®Google Scholar
• Paisey RB, Paisey RM, Thomson MP, et al. Protection from clinical peripheral sensory neuropathy in Alström syndrome in contrast to early-onset type 2 diabetes. Diabetes Care. 2009 Mar;32(3):462–464.
   PubMed Web of Science ®Google Scholar
• Paisey RB, Smith J, Carey C, et al. Duration of diabetes predicts aortic pulse wave velocity and vascular events in Alström syndrome. J Clin Endocrinol Metab. 2015 Aug;100(8):E1116–1124.
   Google Scholar
• Sinha SK, Bhangoo A, Anhalt H, et al. Effect of metformin and rosiglitazone in a prepubertal boy with Alström syndrome. J Pediatr Endocrinol Metab. 2007 Sep;20(9):1045–1052.
   PubMed Web of Science ®Google Scholar
• Minton JAL, Owen KR, Ricketts CJ, et al. Syndromic obesity and diabetes: changes in body composition with age and mutation analysis of ALMS1 in 12 United Kingdom kindreds with Alstrom syndrome. J Clin Endocrinol Metab. 2006 Aug;91(8):3110–3116.
   PubMed Web of Science ®Google Scholar
• Paisey RB, Hodge D, Williams K. Body fat distribution, serum glucose, lipid and insulin response to meals in Alström syndrome. J Hum Nutr Dietetics. 2008;21(3):268–274.
   Google Scholar
• Paisey RB. New insights and therapies for the metabolic consequences of Alström syndrome. Curr Opin Lipidol. 2009 Aug;20(4):315–320.
   PubMed Web of Science ®Google Scholar
• Li G, Vega R, Nelms K, et al. A role for Alström syndrome protein, alms1, in kidney ciliogenesis and cellular quiescence. PLoS Genet. 2007 Jan 5;3(1):e8.
   Web of Science ®Google Scholar
• Angeli F, Reboldi G, Mazzotta G, et al. Safety and efficacy of aliskiren in the treatment of hypertension and associated clinical conditions. Curr Drug Saf. 2012 Feb;7(1):76–85.
   PubMedGoogle Scholar
• Chang KW, Hou JW, Lin SJ, et al. Alstrom syndrome with hepatic dysfunction: report of one case. Acta Paediatr Taiwan. 2000 Oct;41(5):270–272.
   PubMedGoogle Scholar
• Quiros-Tejeira RE, Vargas J, Marvin E. Ament. Early-onset liver disease complicated with acute liver failure in Alstrom syndrome. Am J Med Genet. 2001 Jun 1;101(1):9–11.
   PubMed Web of Science ®Google Scholar
• Irvine KM, Wockner LF, Shanker M, et al. The enhanced liver fibrosis score is associated with clinical outcomes and disease progression in patients with chronic liver disease. Liver Int. 2016 Mar;36(3):370–377.
   PubMed Web of Science ®Google Scholar
• Foucher J, Chanteloup E, Vergniol J, et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut. 2006 Mar;55(3):403–408.
   PubMed Web of Science ®Google Scholar
• Maffei P, Boschetti M, Marshall JD, et al. Characterization of the IGF system in 15 patients with Alström syndrome. Clin Endocrinol (Oxf). 2007 Feb;66(2):269–275.
   PubMed Web of Science ®Google Scholar
• Alter CA, Moshang T Jr. Growth hormone deficiency in two siblings with Alström syndrome. Am J Dis Child. 1993 Jan;147(1):97–99.
   PubMedGoogle Scholar
• Ozgül RK, Satman I, Collin GB, et al. Molecular analysis and long-term clinical evaluation of three siblings with Alström syndrome. Clin Genet. 2007 Oct;72(4):351–356.
   PubMed Web of Science ®Google Scholar
• Citton V, Maffei P, Marshall JD, et al. Pituitary morphovolumetric changes in Alström syndrome. J Neuroradiol. 2015 Dec 15 pii: S0150-9861(15)00146–7. doi:10.1016/j.neurad.2015.10.005. [Epub ahead of print].
   PubMedGoogle Scholar
• Khoo EYH, Risley J, Zaitoun AM, et al. Alström syndrome and cecal volvulus in 2 siblings. Am J Med Sci. 2009 May;337(5):383–385.
   PubMed Web of Science ®Google Scholar
• Kanna RM, Gradil D, Boszczyk BM Management of cervical myelopathy due to ossification of posterior longitudinal ligament in a patient with Alström syndrome. Eur Spine J [Internet]. 2012 May 11 [cited 2012 Aug 14]; Available from: http://www.ncbi.nlm.nih.gov/pubmed/22576155.
   Google Scholar
• White DRA, Ganesh A, Nishimura D, et al. Autozygosity mapping of Bardet-Biedl syndrome to 12q21.2 and confirmation of FLJ23560 as BBS10. Eur J Hum Genet. 2007 Feb;15(2):173–178.
   PubMed Web of Science ®Google Scholar
• Piñeiro-Gallego T, Cortón M, Ayuso C, et al. Molecular approach in the study of Alström syndrome: analysis of ten Spanish families. Mol Vis. 2012;18:1794–1802.
   PubMedGoogle Scholar
• For a Rare Disease, Drug Trials Scramble for Patients. WSJ [Internet]. [ cited 2016 Apr 18]. Available from: http://www.wsj.com/articles/for-a-rare-disease-drug-trials-scramble-for-patients-1440013683.
   Google Scholar
• Singh MN, Lacro RV. Recent clinical drug trials evidence in Marfan syndrome and clinical implications. Can J Cardiol. 2016 Jan;32(1):66–77.
   PubMed Web of Science ®Google Scholar
• Developments in the management of idiopathic pulmonary fibrosis. Drug Ther Bull. 2015 Jul;53(7):78–81.
   PubMedGoogle Scholar